LENZ Therapeutics, Inc. Liabilities, Current in USD from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: LENZ Therapeutics, Inc. quarterly Liabilities, Current history and growth rate from Q4 2020 to Q3 2025.
LENZ Therapeutics, Inc. Liabilities, Current for the quarter ending September 30, 2025 was $16.3M, a 112% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

LENZ Therapeutics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$16.3M	+$8.61M	+112%	Sep 30, 2025	10-Q	2025-11-05
Q2 2025	$10.4M	+$1.82M	+21.1%	Jun 30, 2025	10-Q	2025-07-30
Q1 2025	$8.57M	-$10.3M	-54.6%	Mar 31, 2025	10-Q	2025-05-07
Q4 2024	$10.4M	-$8.11M	-43.8%	Dec 31, 2024	10-Q	2025-11-05
Q3 2024	$7.71M	-$4.83M	-38.5%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$8.58M	-$3.69M	-30%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$18.9M	+$4.55M	+31.7%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$18.5M	+$5.47M	+41.9%	Dec 31, 2023	10-K	2025-03-19
Q3 2023	$12.5M	-$987K	-7.3%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$12.3M	+$202K	+1.67%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$14.3M	+$1.58M	+12.3%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$13M	+$900K	+7.41%	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$13.5M	+$2.25M	+20%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$12.1M	+$4.21M	+53.6%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$12.8M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$12.1M	-$19.9M	-62.1%	Dec 31, 2021	10-K	2023-03-20
Q3 2021	$11.3M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$7.86M			Jun 30, 2021	10-Q	2021-08-12
Q4 2020	$32M			Dec 31, 2020	10-K	2022-03-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.